Sarena S. Lin files SEC Form 4 disclosures for Elanco Animal Health Inc. They have made 1 open-market trade across 1 company since 2018, most recently 2020-03-02.
CIK 0001598788
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $480K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELAN | BUY | 2018-09-24 | 2018-09-26 | $24.00 | $480K | -9.6% | -13.8% | -18.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.